Analysis of early diagnostic pathway for prostate cancer in Slovenia

  • 0Department of Family Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

|

|

Summary

This summary is machine-generated.

Optimizing prostate cancer (PCa) diagnosis in primary care significantly impacts 5-year survival. Accessible diagnostics and shorter intervals improve outcomes for this common male malignancy.

Area Of Science

  • Oncology
  • Public Health
  • Health Services Research

Background

  • Prostate cancer (PCa) is a leading global male malignancy.
  • Delayed diagnosis correlates with adverse patient outcomes.
  • Optimizing the PCa diagnostic pathway is crucial.

Purpose Of The Study

  • Evaluate doctor and primary care intervals in PCa diagnosis.
  • Assess the impact of these intervals on patient survival.
  • Identify opportunities to enhance the PCa diagnostic pathway within primary care.

Main Methods

  • Retrospective cohort study design.
  • Utilized anonymized primary care data from cancer patients.
  • Incorporated data from the Slovenian Cancer Registry.

Main Results

  • Median doctor interval was 0 days (IQR 0-6); median primary care interval was 5 days (IQR 0-58).
  • Longer intervals associated with multiple comorbidities, limited GP access to diagnostics, and initial symptomatic presentation (dysuria, LUTS, abdominal pain).
  • Reduced 5-year survival linked to limited primary care lab/ultrasound access and symptomatic presentation vs. elevated PSA detection.

Conclusions

  • Primary care management of suspected PCa significantly affects 5-year survival.
  • Enhanced access to laboratory and ultrasound diagnostics in primary care settings improves survival.
  • PCa diagnosis is influenced by systemic factors beyond clinician skill, including diagnostic test and service availability.

Related Concept Videos